Synthetic molecules to stimulate the expression of Frataxin to ameliorate Freidreichs Ataxin
刺激 Frataxin 表达以改善 Freidreichs Ataxin 的合成分子
基本信息
- 批准号:10382433
- 负责人:
- 金额:$ 60.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-07-01 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:AdoptedAfferent NeuronsAntisense OligonucleotidesAtaxiaAttenuatedB-DNACardiac MyocytesCell LineCellsChromatinConsensusCytosineDNADNA MethylationDNA Polymerase IIDNA StructureDNA-Directed RNA PolymeraseDevelopmentDiabetes MellitusDiseaseEpigenetic ProcessEvaluationFragile X SyndromeFriedreich AtaxiaGene ExpressionGene SilencingGenerationsGenesGenetic TranscriptionGenomeHeterochromatinHistone Deacetylase InhibitorHistonesHybridsHypertrophic CardiomyopathyIncidenceIndividualInheritedIntronsInvestigationLeadMapsMessenger RNAMicrosatellite RepeatsMitochondriaModelingMorbidity - disease rateNerve DegenerationNeurodegenerative DisordersNuclearNylonsPatientsPatternPlayPluripotent Stem CellsPrecision therapeuticsProtein DeficiencyProteinsRNARNA chemical synthesisReportingRoleSpecificitySymptomsSyndromeTestingTranscription ElongationTranscriptional Elongation FactorsTrinucleotide Repeatsbasecell typechemical geneticsdesigneffective therapyfrataxinhistone modificationinduced pluripotent stem cellinnovationinsightiron metabolismnext generationnovelpreventprogressive neurodegenerationrational designrecruitrestorationsynergismtooltranscriptometriplex DNA
项目摘要
PROJECT SUMMARY/ABSTRACT
Friedreich's ataxia (FRDA/FA) is the most commonly inherited autosomal recessive neurodegenerative disease
for which there is no cure. This debilitating and ultimately lethal disease occurs due to reduced expression of
frataxin (FXN), a nuclear encoded protein that plays a role in iron metabolism in mitochondria. Homozygous
expansion of GAA triplet repeats in the first intron of FXN silence mRNA synthesis. The resulting FXN protein
deficiency leads to progressive neurodegeneration, hypertrophic cardiomyopathy and even diabetes mellitus. A
novel class of synthetic transcription elongation factors (Syn-TEFs) that target GAA repeat expansions in FXN
and actively stimulate Pol II function across the silenced gene were recently developed by our group. In patient-
derived cells, Syn-TEF1 restores FXN to levels observed in healthy individuals. The premise that underlies this
proposal is that systematic evaluation of the Syn-TEF responsive changes in the epigenetic landscape and/or
the formation of stable unusual DNA structures will reveal the extent to which of these mechanisms contribute
to FXN silencing in patient-derived cells. This understanding will result in more mechanistically-guided design of
the next generation precision-tailored Syn-TEFs. Moreover, testing Syn-TEFs in cell types where FXN deficiency
results in ataxia and morbidity is a first step toward the development of genome-targeted precision therapeutics.
项目总结/摘要
弗里德赖希共济失调(FRDA/FA)是最常见的常染色体隐性遗传性神经退行性疾病
无法治愈这种使人衰弱并最终致命的疾病的发生是由于以下因素的表达减少:
共济失调蛋白(FXN),一种在线粒体中的铁代谢中起作用的核编码蛋白。纯合
FXN沉默mRNA合成的第一内含子中GAA三联体重复的扩增。FXN蛋白
缺乏导致进行性神经变性、肥厚性心肌病甚至糖尿病。一
靶向FXN中GAA重复扩增的新型合成转录延伸因子(Syn-TEF)
并积极刺激沉默基因的Pol II功能。在病人-
通过使用衍生细胞,Syn-TEF 1将FXN恢复到在健康个体中观察到的水平。这背后的前提是
建议系统评价Syn-TEF对表观遗传景观和/或
稳定的不寻常DNA结构的形成将揭示这些机制在多大程度上起作用
到患者来源的细胞中的FXN沉默。这种理解将导致更多的机械引导设计,
下一代精确定制的Syn-TEFs此外,在FXN缺乏的细胞类型中测试Syn-TEFs,
导致共济失调和发病率是发展基因组靶向精确治疗的第一步。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
S1-END-seq reveals DNA secondary structures in human cells.
- DOI:10.1016/j.molcel.2022.08.007
- 发表时间:2022-10-06
- 期刊:
- 影响因子:16
- 作者:Matos-Rodrigues, Gabriel;van Wietmarschen, Niek;Wu, Wei;Tripathi, Veenu;Koussa, Natasha C.;Pavani, Raphael;Nathan, William J.;Callen, Elsa;Belinky, Frida;Mohammed, Ashraf;Napierala, Marek;Usdin, Karen;Ansari, Aseem Z.;Mirkin, Sergei M.;Nussenzweig, Andre
- 通讯作者:Nussenzweig, Andre
In search of chemical rationales
寻找化学原理
- DOI:10.1038/s41589-023-01488-y
- 发表时间:2023
- 期刊:
- 影响因子:14.8
- 作者:Ansari, Aseem Z.
- 通讯作者:Ansari, Aseem Z.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ASEEM Z ANSARI其他文献
ASEEM Z ANSARI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ASEEM Z ANSARI', 18)}}的其他基金
Synthetic molecules to stimulate the expression of Frataxin to ameliorate Freidreichs Ataxin
刺激 Frataxin 表达以改善 Freidreichs Ataxin 的合成分子
- 批准号:
10078821 - 财政年份:2018
- 资助金额:
$ 60.85万 - 项目类别:
Revealing Masked Specificities of Human Nuclear Receptors
揭示人类核受体的隐藏特性
- 批准号:
10078820 - 财政年份:2016
- 资助金额:
$ 60.85万 - 项目类别:
Revealing masked specificities of human Nuclear Receptors
揭示人类核受体的隐藏特性
- 批准号:
9356561 - 财政年份:2016
- 资助金额:
$ 60.85万 - 项目类别:
STRUCTURE AND DNA BINDING STUDIES OF NANOG, SOX2, AND OCT4
NANOG、SOX2 和 OCT4 的结构和 DNA 结合研究
- 批准号:
8361239 - 财政年份:2011
- 资助金额:
$ 60.85万 - 项目类别:
Modular design of synthetic transcriptional regulators
合成转录调节因子的模块化设计
- 批准号:
8031050 - 财政年份:2010
- 资助金额:
$ 60.85万 - 项目类别:
SYNTHESIS OF PNA-ENCODED COMBINATORIAL PEPTIDE LIBRARIES
PNA 编码的组合肽库的合成
- 批准号:
7954648 - 财政年份:2009
- 资助金额:
$ 60.85万 - 项目类别:
相似海外基金
How Spinal Afferent Neurons Control Appetite and Thirst
脊髓传入神经元如何控制食欲和口渴
- 批准号:
DP220100070 - 财政年份:2023
- 资助金额:
$ 60.85万 - 项目类别:
Discovery Projects
The mechanisms of the signal transduction from brown adipocytes to afferent neurons and its significance.
棕色脂肪细胞向传入神经元的信号转导机制及其意义。
- 批准号:
23K05594 - 财政年份:2023
- 资助金额:
$ 60.85万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Neurobiology of Intrinsic Primary Afferent Neurons
内在初级传入神经元的神经生物学
- 批准号:
10477437 - 财政年份:2021
- 资助金额:
$ 60.85万 - 项目类别:
GPR35 on Vagal Afferent Neurons as a Peripheral Drug Target for Treating Diet-Induced Obesity
迷走神经传入神经元上的 GPR35 作为治疗饮食引起的肥胖的外周药物靶点
- 批准号:
10315571 - 财政年份:2021
- 资助金额:
$ 60.85万 - 项目类别:
Neurobiology of Intrinsic Primary Afferent Neurons
内在初级传入神经元的神经生物学
- 批准号:
10680037 - 财政年份:2021
- 资助金额:
$ 60.85万 - 项目类别:
Neurobiology of Intrinsic Primary Afferent Neurons
内在初级传入神经元的神经生物学
- 批准号:
10654779 - 财政年份:2021
- 资助金额:
$ 60.85万 - 项目类别:
Neurobiology of Intrinsic Primary Afferent Neurons
内在初级传入神经元的神经生物学
- 批准号:
10275133 - 财政年份:2021
- 资助金额:
$ 60.85万 - 项目类别:
GPR35 on Vagal Afferent Neurons as a Peripheral Drug Target for Treating Diet-Induced Obesity
迷走神经传入神经元上的 GPR35 作为治疗饮食引起的肥胖的外周药物靶点
- 批准号:
10470747 - 财政年份:2021
- 资助金额:
$ 60.85万 - 项目类别:
Roles of mechanosensory ion channels in myenteric intrinsic primary afferent neurons
机械感觉离子通道在肌间固有初级传入神经元中的作用
- 批准号:
RGPIN-2014-05517 - 财政年份:2018
- 资助金额:
$ 60.85万 - 项目类别:
Discovery Grants Program - Individual
Roles of mechanosensory ion channels in myenteric intrinsic primary afferent neurons
机械感觉离子通道在肌间固有初级传入神经元中的作用
- 批准号:
RGPIN-2014-05517 - 财政年份:2017
- 资助金额:
$ 60.85万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




